News

OCRF Research Finds Combination Immunotherapy Promising

OCRF Research Finds Combination Immunotherapy Promising

August 19, 2015

(August 19, 2015) Whereas chemotherapy kills cancer cells only while it is being administered, immunotherapy can lead to an adaptive immune response that persists long after treatment is ceased. By simple analogy, whereas aspirin provides temporary pain relief, a polio vaccine provides lifelong protection. Unfortunately, just as tumors develop resistance to conventional therapies, tumors also … Continued

New York Times Letter to the Editor

New York Times Letter to the Editor

August 13, 2015

On August 3, 2015 the New York Times published an article about the use of IP chemotherapy in the treatment of ovarian cancer. Our CEO, Calaneet Balas joined with Ovarian Cancer Research Fund CEO, Audra Moran, to write a response to the New York Times. Click the plus sign to see their Letter to the Editor.

The New York Times Publishes OCRF’s Letter to the Editor 8/...

The New York Times Publishes OCRF’s Letter to the Editor 8/12/15

August 12, 2015

(8/12/15) In response to the article “An Ovarian Cancer Treatment, Recommended Since 2006, is Found to be Underused,“ published in the Health section of The New York Times on August 3, 2015, OCRF co-wrote a Letter to the Editor along with Ovarian Cancer National Alliance, strongly encouraging physicians and treatment centers to fully consider and communicate all treatment … Continued

Ovarian Cancer Research Fund and National Sponsor QVC Expan...

Ovarian Cancer Research Fund and National Sponsor QVC Expand Woman to Woman Program

August 10, 2015

Gynecologic Cancer Patients to Receive Support in 6 New Locations WEST CHESTER, Pa (August 10, 2015) —Ovarian Cancer Research Fund (OCRF) and QVC today announced six new Woman to Woman grant recipients: Cooper University Hospital, Camden, New Jersey; Shanti Project/Kaiser Permanente, San Francisco, California; Northside Hospital Cancer Center, Atlanta, Georgia; The University of Alabama at … Continued

OCRF Research Finds Gene Therapy May Help Patients with Rec...

OCRF Research Finds Gene Therapy May Help Patients with Recurrent Ovarian Cancer

July 30, 2015

(July 30, 2015) Recurrent ovarian cancer patients have more hope today, thanks to OCRF-funded research by David Pepin, PhD at Massachusetts General Hospital. Dr. Pepin and his colleagues found that gene therapy that delivers a protein that suppresses the development of female reproductive organs may improve survival rates in patients with ovarian cancer that has … Continued

OCRF Research Shows PARP/Immune Therapy Combo Shows Promise

OCRF Research Shows PARP/Immune Therapy Combo Shows Promise

July 23, 2015

(July 23, 2015) New OCRF-funded research demonstrates that combining a PARP-inhibitor with immune therapy results in tumor rejection and long-term survival in a mouse model of BRCA1-deficient ovarian cancer.  The study, published in Cancer Immunology Research, was funded by an OCRF Liz Tilberis Early Career Award to Sarah Adams, MD. The benefit of this combination … Continued

QVC Heads to the Hamptons for Annual Charitable Broadcast

QVC Heads to the Hamptons for Annual Charitable Broadcast

July 21, 2015

QVC and Ovarian Cancer Research Fund Joining Forces for “QVC Presents Super Saturday LIVE” Broadcast WEST CHESTER, Pa. (July 21, 2015) – Help advance the fight against ovarian cancer with stylish steals and dazzling deals. QVC and Ovarian Cancer Research Fund (OCRF) are uniting once again for “QVC Presents Super Saturday LIVE,” an annual designer … Continued

NASCAR’s Martin Truex’s girlfriend Sherry Polle...

NASCAR’s Martin Truex’s girlfriend Sherry Pollex goes to Capitol Hill to advocate for affordable therapy costs, ovarian cancer research funding

July 15, 2015

NASCAR’s Martin Truex Jr.’s girlfriend Sherry Pollex goes to Capitol Hill to advocate for affordable therapy costs, ovarian cancer research funding Pollex, Ovarian Cancer National Alliance support Cancer Treatment Parity Act, to ensure affordable out-of-pocket costs for cancer therapy WASHINGTON, D.C. — Today Sherry Pollex, girlfriend to NASCAR’s Martin Truex Jr. and longtime champion of … Continued

Donna Karan and Kelly Ripa to Host Ovarian Cancer Research ...

Donna Karan and Kelly Ripa to Host Ovarian Cancer Research Fund's Super Saturday NY

July 7, 2015

WORLD FAMOUS DESIGNER GARAGE SALE SPONSORED BY QVC SATURDAY, JULY 25TH IN WATER MILL, NY NEW YORK, N.Y. – July 7, 2015 – Donna Karan and Kelly Ripa will host Ovarian Cancer Research Fund’s (OCRF) 18th annual Super Saturday NY, sponsored by QVC. Super Saturday NY will take place on Saturday, July 25, 2015, at … Continued

OCRF Welcomes New Scientific Advisory Committee Members

OCRF Welcomes New Scientific Advisory Committee Members

June 19, 2015

(6/19/15) OCRF recently welcomed three new members to the Scientific Advisory Committee (SAC), our world-class group of leaders in the ovarian cancer field who review and approve all OCRF research grants. Dineo Khabele, M.D., of Vanderbilt University Medical Center, Celeste Leigh Pearce, Ph.D., M.P.H., of University of Michigan, and Daniel J. Powell, Jr., Ph.D., of … Continued

OCRF Researchers Find Clues on Mucinous Ovarian Cancer Origins

OCRF Researchers Find Clues on Mucinous Ovarian Cancer Origins

June 19, 2015

(June 19, 2015) In a recent study, funded in part by OCRF grants to Dr. Simon Gayther and Dr. Andrew Berchuck, researchers have made important breakthroughs toward understanding the risk and growth of a certain kind of ovarian cancer, known as mucinous ovarian carcinoma, or MOC. The international study involving 1,644 women with MOC and … Continued

Rosalind Franklin Excellence in Ovarian Cancer Research Award

Rosalind Franklin Excellence in Ovarian Cancer Research Award

May 26, 2015

Introducing the 2015 Ovarian Cancer National Conference Rosalind Franklin Excellence in Ovarian Cancer Research Award winner: Beth Karlan, MD. The Rosalind Franklin Excellence in Ovarian Cancer Research Award is named for the molecular biologist Dr. Rosalind Elsie Franklin, who played a vital role in discovering the structure of DNA. Her career was cut short in 1958 when she died of ovarian cancer at age 37. Throughout her life, she was a committed researcher; this award honors an individual who continues her legacy of excellence. Beth Karlan, MD is the Director of the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology, and Director of the Gilda Radner Hereditary Cancer Program. Click the plus sign to read more.